title: Methicillin-resistant Staphylococcus aureus in burns patients--why all the fuss?
abstract: Procedures designed to limit spread of methicillin-resistant Staphylococcus aureus (MRSA) in burns units demand time and resources. To assess the significance of MRSA in burns patients we performed a retrospective review of MRSA colonization in in-patients over a 41-month period at the North Trent Sub-regional Burns Unit. Patients were compared with MRSA free controls, matched for age and percentage body surface area (BSA) burn and admitted during the same time period. Length of stay, number of operations and deaths were outcome indicators. All patients managed non-operatively were excluded, leaving 40 MRSA patients and 46 controls. There was no statistical difference between the two groups with regard to number of operations (p= 0.07), duration of admission (p = 0.12) or mortality (p = 0.09). Of the control group, 83% had wound swabs positive for methicillin-sensitive Staphylococcus aureus (MSSA). there was no statistical difference in any outcome variables between this sub-group of controls and MRSA patients. Colonization with S. aureus (both MRSA and MSSA) was associated with larger burns (p<0.05), twice as many operative procedures (p<0.05) and prolonged admissions (p<0.01). Mortality was unaltered by staphylococcal colonization (p = 0.8). Although our study lacks power, we would suggest that methicillin resistance per se is not associated with increased morbidity or mortality in burns patients.
authors.affiliation: Department of Plastic, Reconstructive and Burns Surgery, Northern General Hospital, Sheffield, UK.
authors.forename: C M
authors.initials: CM
authors.lastname: Reardon
authors.forename: T P
authors.initials: TP
authors.lastname: Brown
authors.forename: A J
authors.initials: AJ
authors.lastname: Stephenson
authors.forename: E
authors.initials: E
authors.lastname: Freedlander
mesh_terms: D000328:Adult; D002053:Burn Units / Q000706:statistics & numerical data; D002056:Burns / Q000382:microbiology*; D016022:Case-Control Studies; D015169:Colony Count, Microbial; D003428:Cross Infection / Q000517:prevention & control*; D005260:Female; D006801:Humans; D015994:Incidence; D017053:Infection Control / Q000379:methods*; D007902:Length of Stay; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D018709:Statistics, Nonparametric; D015996:Survival Rate; D006113:United Kingdom